Bekker J, Ploem S, de Jong K P
Department of Hepato-Pancreatico-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Am J Transplant. 2009 Apr;9(4):746-57. doi: 10.1111/j.1600-6143.2008.02541.x. Epub 2009 Mar 2.
To clarify inconsistencies in the literature we performed a systematic review to identify the incidence, risk factors and outcome of early hepatic artery thrombosis (eHAT) after liver transplantation. We searched studies identified from databases (MEDLINE, EMBASE, Science Citation Index) and references of identified studies. Seventy-one studies out of 999 screened abstracts were eligible for this systematic review. The incidence of eHAT was 4.4% (843/21, 822); in children 8.3% and 2.9% in adults (p < 0.001). Doppler ultrasound screening (DUS) protocols varied from 'no routine' to 'three times a day.' The median time to detection was at day seven. The overall retransplantation rate was 53.1% and was higher in children (61.9%) than in adults (50%, p < 0.03). The overall mortality rate of patients with eHAT was 33.3% (range: 0-80%). Mortality in adults (34.3%) was higher than in children (25%, p < 0.03). The reported risk factors for eHAT were, cytomegalovirus mismatch (seropositive donor liver in seronegative recipient), retransplantation, arterial conduits, prolonged operation time, low recipient weight, variant arterial anatomy, and low volume transplantation centers. eHAT is associated with significant graft loss and mortality. Uniform definitions of eHAT and uniform treatment modalities are obligatory to confirm these results and to obtain a better understanding of this disastrous complication.
为了澄清文献中的不一致之处,我们进行了一项系统评价,以确定肝移植后早期肝动脉血栓形成(eHAT)的发生率、危险因素和结局。我们检索了从数据库(MEDLINE、EMBASE、科学引文索引)中识别出的研究以及已识别研究的参考文献。999篇筛选摘要中有71项研究符合该系统评价的要求。eHAT的发生率为4.4%(843/21,822);儿童为8.3%,成人为2.9%(p<0.001)。多普勒超声筛查(DUS)方案从“无常规筛查”到“每天三次”不等。检测的中位时间为第7天。总体再次移植率为53.1%,儿童(61.9%)高于成人(50%,p<0.03)。eHAT患者的总体死亡率为33.3%(范围:0-80%)。成人死亡率(34.3%)高于儿童(25%,p<0.03)。报道的eHAT危险因素包括巨细胞病毒不匹配(血清学阴性受者接受血清学阳性供体肝脏)、再次移植、动脉导管、手术时间延长、受者体重低、动脉解剖变异和低容量移植中心。eHAT与显著的移植物丢失和死亡率相关。对eHAT进行统一的定义和统一的治疗方式对于证实这些结果以及更好地理解这一致命并发症是必不可少的。